LIVE

Serial Number

97473474

Owner

Scribe Therapeutics Inc.

Attorney

John Paul Oleksiuk

Filing Date

Jun 23, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

X SCRIBE THERAPEUTICS Trademark

Serial Number: 97473474 • Registration: 8145751

X SCRIBE THERAPEUTICS is a trademark filed by Scribe Therapeutics Inc. on June 23, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Scribe Therapeutics Inc. (12 trademarks)

Alameda, CA 94501

Entity Type: 03

Legal Representation

Attorney of Record

John Paul Oleksiuk

2,814 trademarks filed View all →

Correspondence Address

John Paul Oleksiuk COOLEY LLP

1299 PENNSYLVANIA AVENUE, NW, SUITE 700

WASHINGTON, NY 20004

United States

Trademark Details

Filing Date

June 23, 2022

Registration Date

February 17, 2026

Published for Opposition

April 25, 2023

Goods & Services

Scientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations, and therapeutic products and services; Design and development of engineered cells for use in scientific research and in drug discovery and development; Providing medical and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic transcriptional regulation, genetic transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering

Filing History

TEAS SECTION 7 REQUEST RECEIVED

May 4, 2026 ES7R

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 17, 2026 NRCC

REGISTERED-PRINCIPAL REGISTER

Feb 17, 2026 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 27, 2026 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 27, 2026 CNPR

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 19, 2025 EXRA

STATEMENT OF USE PROCESSING COMPLETE

Dec 19, 2025 SUPC

SOU EXTENSION 4 GRANTED

Dec 19, 2025 EX4G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 19, 2025 AITU

USE AMENDMENT FILED

Jun 18, 2025 IUAF

TEAS STATEMENT OF USE RECEIVED

Jun 18, 2025 EISU

SOU TEAS EXTENSION RECEIVED

Jun 18, 2025 EEXT

SOU EXTENSION 4 FILED

Jun 17, 2025 EXT4

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 3, 2025 EXRA

SOU EXTENSION 3 GRANTED

Dec 16, 2024 EX3G

SOU EXTENSION 3 FILED

Dec 16, 2024 EXT3

SOU TEAS EXTENSION RECEIVED

Dec 15, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 13, 2024 EXRA

SOU EXTENSION 2 GRANTED

Jun 11, 2024 EX2G

SOU EXTENSION 2 FILED

Jun 11, 2024 EXT2

SOU TEAS EXTENSION RECEIVED

Jun 11, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 12, 2023 EXRA

SOU EXTENSION 1 GRANTED

Dec 10, 2023 EX1G

SOU EXTENSION 1 FILED

Dec 10, 2023 EXT1

SOU TEAS EXTENSION RECEIVED

Dec 10, 2023 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 20, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 25, 2023 NPUB

PUBLISHED FOR OPPOSITION

Apr 25, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 5, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 16, 2023 CNSA

EXAMINER'S AMENDMENT ENTERED

Mar 16, 2023 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 16, 2023 GNEN

EXAMINERS AMENDMENT E-MAILED

Mar 16, 2023 GNEA

EXAMINERS AMENDMENT -WRITTEN

Mar 16, 2023 CNEA

ASSIGNED TO EXAMINER

Mar 9, 2023 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jul 13, 2022 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 12, 2022 NWOS

NEW APPLICATION ENTERED

Jun 27, 2022 NWAP

Related Trademarks

More from this Owner

SCRIBE THERAPEUTICS

CRISPR BY DESIGN

ELXR

More in Same Class

PROMS